Eduardo Bruno Martins

Insider Reports History

Location
Palo Alto, CA
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eduardo Bruno Martins:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sagimet Biosciences Inc. Chief Medical Officer Series A Common Stock 147,296 $863,154 $5.86 19 Feb 2026 Direct
Sagimet Biosciences Inc. Chief Medical Officer Stock Option (Right to Buy) 88,000 19 Feb 2026 Direct

Insider Reports Filed by Eduardo Bruno Martins

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SGMT Sagimet Biosciences Inc. 19 Feb 2026 2 $0 4 Chief Medical Officer 20 Feb 2026, 16:42
SGMT Sagimet Biosciences Inc. 10 Feb 2026 1 -$19,511 4 Chief Medical Officer 12 Feb 2026, 16:06
SGMT Sagimet Biosciences Inc. 21 Jul 2025 1 -$75,607 4 Chief Medical Officer 23 Jul 2025, 16:15
SGMT Sagimet Biosciences Inc. 06 Feb 2025 2 $0 4 Chief Medical Officer 07 Feb 2025, 16:44
SGMT Sagimet Biosciences Inc. 19 Jul 2024 1 -$25,910 4 Chief Medical Officer 23 Jul 2024, 16:06
SGMT Sagimet Biosciences Inc. 17 Nov 2023 1 $0 4 Chief Medical Officer 21 Nov 2023, 16:23
SGMT Sagimet Biosciences Inc. 18 Jul 2023 4 $0 4 Chief Medical Officer 20 Jul 2023, 16:17
SGMT Sagimet Biosciences Inc. 13 Jul 2023 0 $0 3 Director 13 Jul 2023, 21:04